Register
Login:
Share:
Email Facebook Twitter


ETF Securities experts James Butterfill and Townsend Lansing: did you know you can go long and short on ETF's?


Quantum Phar. Share Price (QP.)



Share Price Information for Quantum Phar. (QP.)


Share Price: 78.375Bid: 78.25Ask: 78.50Change: 0.00 (0.00%)No Movement on Quantum Phar.
Spread: 0.25Spread as %: 0.32%Open: 78.25High: 78.75Low: 78.25Yesterday’s Close: 78.375

Quantum Pharma Plc Ord 10P

Quantum Phar. is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
78.375

Share Price SpacerBid
78.25

Share Price SpacerAsk
78.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
7,162,563

Share Price SpacerOpen
78.25

Share Price SpacerHigh
78.75

Share Price SpacerLow
78.25

Share Price SpacerClose
78.375

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 169.12m £132.76m 5,000

52 Week High 79.50 52 Week High Date 13-SEP-2017
52 Week Low 33.00 52 Week Low Date 17-OCT-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
167 2,333,555 1,903,896 -11.716 -6.70 1.00 1.27


London South East Users info for Quantum Phar.




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Sep-17
15:28:46
78.375
125,000
 
78.25
78.50
97.97k
Trade Type:
Ordinary
Delayed publication
Historical
Was reported as OTC
Bargain conditions apply

21-Sep-17
15:28:46
78.375
125,000
 
78.25
78.50
97.97k
Trade Type:
Ordinary
Delayed publication
Bargain conditions apply

21-Sep-17
14:49:09
78.1397
120,000
Sell* 
78.25
78.50
93.77k
Trade Type:
Ordinary
Delayed publication
Bargain conditions apply




View more Quantum Phar. trades >>

Directors Deals for Quantum Phar. (QP.)
Trade DateActionNotifierPriceCurrencyAmountHolding
20-Oct-16Placing
Trade Notifier Information for Quantum Pharma
Chris Rigg held the position of CEO at Quantum Pharma at the time of this trade.
 Chris Rigg
34GBX147,059162059
20-Oct-16Placing
Trade Notifier Information for Quantum Pharma
Ian Johnson held the position of Non-Executive Chairman at Quantum Pharma at the time of this trade.
 Ian Johnson
34GBX58,82458824
20-Oct-16Placing
Trade Notifier Information for Quantum Pharma
John E Brown held the position of Senior Independent Non-Executive Director at Quantum Pharma at the time of this trade.
 John E Brown
34GBX73,52973529
View more Quantum Phar. directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Sat 01:04rylidanRE: Outa here.78.375No Opinion
I was always going to invest my cash back into clin. Its far better to put the cash in while the share price has dipped. Thats why i sold.
Sat 01:02rylidanRE: Outa here.78.375No Opinion
The 82p assumes clin is at 1111p. At 1030p the offer is only worth 78.25p. I sold at 77.87p but converted the lot into clin. When clin reaches 1111p and im sure it will it will be equivalent of an 85p offer. If clin reaches 1200 which is quite possible the offer will be worth 37p plus 48p or around 85p while my shares will be worth equivalent of 93p offer.
Fri 18:55boxerdog1Outa here.78.375No Opinion
rylidan cannot see why you've done what you say. I'm assuming you've forgone 5p? of the 82p on offer as you sold out. Selling at 77p and with CLIN. off the 1111p used to value the offer how can this be beneficial or more advantageous than collecting the full 82p and whatever CLIN. climb to.
Thu 08:43rylidanIm Outa here77.75No Opinion
Decided the Clin price is as low as it's going to go. So I've cashed in and transferred the lot to Clinigen. Currently it's more or less parity with the offer, and my 37p cash is now invested

Only risk is that the offer gets rejected, but as it has BoD approval it seems unlikely

Cheers all
Wed 06:07rylidanAlignment to clinigen77.00No Opinion
We are now very closely tied to the clin share price. The initial exedus of quantum PIs taking early profit was probably the cause of the dip in the clin shareprice. Results for clin on 28th sept will drive both the clin and qp. Share price. My guess is that these will be good and our offer price will exceed 90p all in. Also it may be that Chris Riggs has this inside information, and is one of the reasons why the BoD are recommending the takeover.
Mon 18:02CrystalBallBrokeRE: Re: ODDO77.25No Opinion
i'm not sure, way over my head and knowledge/understanding, but as someone pointed out, it's an interesting way to potentially buy into CLIN at a possible small discount, or as robins speculated cynically, it could be funds buying in to support CLIN as they are invested there and it would make sense to protect them.

I still can't beleive we have had nothing from the BoD or Rigg directly, other than the statement in the CLIN offer RNS

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Quantum Phar. (QP.) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.